secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2026-06-08T20:46:52+00:00
Accession:  0001628280-26-041651
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

All proposals approved at 10x Genomics 2026 annual meeting: directors elected, auditor ratified, say-on-pay passes
--------------------------------------------------------------------------------

- Serge Saxonov, Benjamin Hindson, and John Stuelpnagel elected as Class I directors with ~91% of votes cast (excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2026 approved with ~99.4% of votes cast.
- Non-binding advisory vote on executive compensation approved with ~98.4% of votes cast (excluding broker non-votes).
- Approx. 90.5% of eligible votes represented at the meeting; 117.5M shares present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/0001628280-26-041651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000162828026041651/txg-20260604.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-041651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer